Davenport & CO LLC Sanofi Transaction History

Davenport & CO LLC

$16.7 Billion
Q4 2024

A detailed history of Davenport & CO LLC transactions in Sanofi stock. As of the latest transaction made, Davenport & CO LLC holds 2,295,569 shares of SNY stock, worth $120 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

2,295,569

Previous 1,631,114 40.74%

Holding current value

$120 Million

Previous $94.1 Million 17.74%

% of portfolio

0.66%

Previous 0.56%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 24, 2025	BUY	$45.89 - $57.31 $30.5 Million - $38.1 Million	664,455 Added 40.74%	2,295,569 $111 Million
Q3 2024 Oct 24, 2024	BUY	$48.54 - $58.53 $789,600 - $952,107	16,267 Added 1.01%	1,631,114 $94.1 Million
Q2 2024 Aug 06, 2024	BUY	$45.39 - $50.36 $2.98 Million - $3.3 Million	65,618 Added 4.24%	1,614,847 $78.4 Million
Q1 2024 May 03, 2024	BUY	$45.75 - $52.48 $17.3 Million - $19.9 Million	378,860 Added 32.37%	1,549,229 $75.3 Million
Q4 2023 Jan 23, 2024	SELL	$43.13 - $54.79 $1.37 Million - $1.73 Million	-31,657 Reduced 2.63%	1,170,369 $58.2 Million
Q3 2023 Oct 17, 2023	BUY	$50.95 - $55.2 $534,159 - $578,716	10,484 Added 0.88%	1,202,026 $64.5 Million
Q2 2023 Jul 20, 2023	BUY	$50.45 - $57.18 $941,195 - $1.07 Million	18,656 Added 1.59%	1,191,542 $64.2 Million
Q1 2023 Apr 27, 2023	BUY	$45.86 - $54.45 $52.7 Million - $62.5 Million	1,148,092 Added 4630.52%	1,172,886 $63.8 Million
Q4 2022 Jan 20, 2023	BUY	$38.86 - $48.55 $14,339 - $17,914	369 Added 1.51%	24,794 $0
Q3 2022 Oct 11, 2022	SELL	$37.22 - $100.5 $46,115 - $124,519	-1,239 Reduced 4.83%	24,425 $929,000
Q2 2022 Jul 18, 2022	BUY	$48.99 - $57.46 $5,780 - $6,780	118 Added 0.46%	25,664 $1.28 Million
Q1 2022 May 02, 2022	BUY	$48.48 - $53.65 $19,392 - $21,460	400 Added 1.59%	25,546 $1.31 Million
Q4 2021 Feb 10, 2022	BUY	$47.07 - $52.35 $156,366 - $173,906	3,322 Added 15.22%	25,146 $1.26 Million
Q3 2021 Oct 14, 2021	BUY	$47.89 - $53.12 $284,466 - $315,532	5,940 Added 37.4%	21,824 $1.05 Million
Q2 2021 Jul 28, 2021	SELL	$49.36 - $54.25 $2,714 - $2,983	-55 Reduced 0.35%	15,884 $836,000
Q1 2021 Apr 28, 2021	SELL	$45.46 - $50.51 $361,725 - $401,908	-7,957 Reduced 33.3%	15,939 $788,000
Q4 2020 Jan 13, 2021	BUY	$45.3 - $51.62 $39,456 - $44,961	871 Added 3.78%	23,896 $1.16 Million
Q3 2020 Oct 15, 2020	BUY	$49.47 - $53.77 $8,212 - $8,925	166 Added 0.73%	23,025 $1.16 Million
Q2 2020 Jul 28, 2020	SELL	$42.91 - $52.5 $21,283 - $26,040	-496 Reduced 2.12%	22,859 $1.17 Million
Q1 2020 May 05, 2020	BUY	$38.02 - $51.66 $92,882 - $126,205	2,443 Added 11.68%	23,355 $1.02 Million
Q4 2019 Jan 22, 2020	SELL	$44.25 - $50.86 $167,574 - $192,606	-3,787 Reduced 15.33%	20,912 $1.05 Million
Q3 2019 Oct 16, 2019	SELL	$40.34 - $46.64 $9,076 - $10,494	-225 Reduced 0.9%	24,699 $1.07 Million
Q2 2019 Jul 10, 2019	BUY	$40.43 - $44.3 $16,455 - $18,030	407 Added 1.66%	24,924 $1.08 Million
Q1 2019 Apr 17, 2019	SELL	$40.83 - $45.43 $567,577 - $631,522	-13,901 Reduced 36.18%	24,517 $1.09 Million
Q4 2018 Jan 28, 2019	BUY	$41.48 - $45.59 $105,691 - $116,163	2,548 Added 7.1%	38,418 $1.67 Million
Q3 2018 Oct 11, 2018	SELL	$40.0 - $44.84 $38,560 - $43,225	-964 Reduced 2.62%	35,870 $1.6 Million
Q2 2018 Jul 09, 2018	SELL	$37.63 - $41.22 $81,167 - $88,911	-2,157 Reduced 5.53%	36,834 $1.47 Million
Q1 2018 Apr 04, 2018	SELL	$38.98 - $45.76 $211,778 - $248,614	-5,433 Reduced 12.23%	38,991 $1.56 Billion
Q4 2017 Jan 17, 2018	SELL	$42.86 - $50.61 $144,138 - $170,201	-3,363 Reduced 7.04%	44,424 $1.91 Billion
Q3 2017 Oct 12, 2017	BUY	$47.04 - $50.34 $2.25 Million - $2.41 Million	47,787	47,787 $2.38 Billion

Others Institutions Holding SNY

# of Institutions

806

Shares Held

267M

Call Options Held

Put Options Held

1.9M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $132B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Account